Vimian Group ABVIMGF 75 EV-to-FCF is 16.96 as of Jun. 27, 2026, which is 60% below its 10-year median of 42.75. GuruFocus rates VIMGF with a GF Score™ of 75/100 and a GF Value™ of $3.26. The stock has 2 warning signs investors should review. Among 98 Medical Diagnostics & Research companies, Vimian Group AB ranks better than 62.24% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Vimian Group AB's Enterprise Value is $1,835.3 Mil.
Vimian Group AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $108.2 Mil. Therefore, Vimian Group AB's EV-to-FCF for today is 16.96.
The historical rank and industry rank for Vimian Group AB's EV-to-FCF or its related term are showing as below:
VIMGF'
s EV-to-FCF Range Over the Past 10 Years
Min: -242.51 Med: 42.75 Max: 738.73
Current: 17.67
During the past 9 years, the highest EV-to-FCF of Vimian Group AB was 738.73. The lowest was -242.51. And the median was 42.75.
VIMGF's EV-to-FCF is ranked better than 62.24% of 98
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.585
vs VIMGF: 17.67
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Vimian Group AB (OTCPK:VIMGF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Vimian Group AB's PE Ratio (TTM) for today is calculated as:
Vimian Group AB's share price for today is $2.77.
Vimian Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.081.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Vimian Group AB EV-to-FCF Related Terms
Vimian Group AB EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Vimian Group AB's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Vimian Group AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimian Group AB EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Vimian Group AB's EV-to-FCF falls into.
Vimian Group AB's current Enterprise Value is $1,835.3 Mil.
Vimian Group AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $108.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimian Group AB (VIMGF) has a EV-to-FCF of 16.96 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Vimian Group AB and its competitors. This is 60% below median its historical median of 42.75. According to the industry distribution chart, Vimian Group AB ranks #37 out of 98 companies in the Medical Diagnostics & Research industry, placing it in the top 37.8%.
Is Vimian Group AB's EV-to-FCF too high?
Vimian Group AB's current EV-to-FCF of 16.96 is 60% below median its 10-year median of 42.75. The Medical Diagnostics & Research industry median EV-to-FCF is 22.59. Vimian Group AB's value of 16.96 is 24.9% below this industry median. Based on the distribution chart, Vimian Group AB ranks #37 out of 98 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Vimian Group AB has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Vimian Group AB's EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vimian Group AB ranks #37 out of 98 companies for EV-to-FCF. This puts Vimian Group AB in the upper half of its industry. The industry median EV-to-FCF is 22.59. Vimian Group AB's value of 16.96 is 24.9% below this benchmark. While the company's 10-year median is 42.75 vs. the industry median of 22.59, Vimian Group AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 22.59, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vimian Group AB's current EV-to-FCF of 16.96 is 24.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Vimian Group AB and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 22.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimian Group AB's current EV-to-FCF is 16.96, which is 60% below median its own 10-year median of 42.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimian Group AB stock overvalued right now?
Vimian Group AB (VIMGF) has a current EV-to-FCF of 16.96. The stock's GF Value™ is $3.26, compared to a current price of $2.77 — trading 15% below its estimated fair value. The current EV-to-FCF is 16.96, which is 60% below median its 10-year median of 42.75 and 24.9% below the Medical Diagnostics & Research industry median of 22.59. Vimian Group AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Vimian Group AB (VIMGF), the current EV-to-FCF is 16.96 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimian Group AB (VIMGF) Overvalued in 2026?
Based on GuruFocus' analysis, Vimian Group AB stock appears to be undervalued.
The current stock price of $2.77 is trading 15% below its estimated GF Value™ of $3.26.
Key valuation signals for VIMGF:
EV-to-FCF: 16.96 (60% below median its 10-year median of 42.75)
GF Value™: $3.26 vs. price of $2.77 (15% below fair value)
Industry Position: 24.9% below the Medical Diagnostics & Research median (#37 of 98)
No single metric tells the full story. See the VIMGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
75GF Score
Get the complete analysis for VIMGF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VIMGF has been successfully added to your 
